Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan

BACKGROUND: The effectiveness of fremanezumab in treating migraine has been demonstrated in randomized controlled trials. However, real-world study results are still limited. METHODS: We conducted a single-center, observational study that included patients with episodic migraine (EM) and chronic mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shiho, Suzuki, Keisuke, Shiina, Tomohiko, Haruyama, Yasuo, Hirata, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359132/
https://www.ncbi.nlm.nih.gov/pubmed/37483436
http://dx.doi.org/10.3389/fneur.2023.1220285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359132/
https://www.ncbi.nlm.nih.gov/pubmed/37483436
http://dx.doi.org/10.3389/fneur.2023.1220285

Ejemplares similares